Press Release

Nov, 06 2023

Elevating Beauty: Insights into the Expanding Aesthetics Market and Its Transformative Impact on Self-Enhancement

The aesthetics market is characterized by continuous innovations and advancements. These developments range from non-invasive treatments such as dermal fillers and Botox to more complex surgical procedures. Advanced technologies such as laser therapies, 3D printing for customized implants, and AI-driven consultations are revolutionizing the field. The introduction of regenerative medicine techniques is opening new possibilities. Furthermore, the market is witnessing a surge in personalized and minimally invasive procedures, reflecting a growing preference for natural-looking results with reduced downtime and risks.

Access Full Report @ https://www.databridgemarketresearch.com/reports/central-europe-aesthetics-market

Data Bridge Market Research analyses that the Central Europe Aesthetics Market value, which was USD 1,675.29 million in 2022, is expected to reach the value of USD 3,437.39 million by 2030, at a CAGR of 9.4% during the forecast period 2023-2030. In the aesthetics market, the influence of visual platforms, such as social media and image-focused websites, plays a pivotal role. These platforms create awareness, showcase real-life transformations, and spark beauty trends, driving individuals to seek aesthetic enhancements and treatments.

Key Findings of the Study

Central Europe Aesthetics Market

Aging population is expected to drive the market's growth rate

In the aesthetics market, the demand for anti-aging treatments is significantly bolstered by the aging demographic. As the population ages, a growing desire exists to maintain a youthful appearance. This trend fuels the demand for various cosmetic procedures, from wrinkle-reducing injectable to skin rejuvenation treatments. Aesthetic providers and products cater to this demographic, offering solutions that help individuals combat the signs of aging and boost their self-confidence.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product (Device, Topical Drugs), Application (Invasive Procedures and Non-invasive Procedures), End User (Hospitals, Clinics, Dermatology Clinics, Academic and Private Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales)

Countries Covered

 Germany, Russia, Denmark, Poland, Belgium, Ireland, Austria, Switzerland, Netherlands, Czech Republic, Ukraine, Rest of CIS Countries and Rest of Central Europe

Market Players Covered

Johnson & Johnson Services, Inc (U.S.), GALDERMA LABORATORIES, L.P. (U.S.), Abbvie, Inc (U.S.), Merz Pharmaceuticals, LLC. (U.S.), POLYTECH Health & Aesthetics GmbH (Germany), Cynosure Inc. (U.S.), Bausch Health Companies Inc. (Canada), LUTRONIC (South Korea), Fotona (U.S.), Sebbin (France), Anika Therapeutics, Inc. (U.S.), Sciton (U.S.), Parc Haute Technologie (France), Pharmann sp. z o. o. (Poland), Sinclair (U.S.)

Data Points Covered in the Report

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Segment Analysis:

The Central Europe aesthetics market is segmented on the basis of product, application, end users, and distribution channel.

  • On the basis of product, the Central Europe aesthetics market is segmented into device, topical, and drugs.
  • On the basis of application, the Central Europe aesthetics market is segmented into invasive procedures and non-invasive procedures.
  • On the basis of end users, the Central Europe aesthetics market is segmented into hospitals, clinics, dermatology clinics, academic and private research institutes, and others.
  • On the basis of distribution channel, the Central Europe aesthetics market is segmented into direct tender, retail sales, and online sales.

Major Players

Data Bridge Market Research recognizes the following companies as the Central Europe aesthetics market players in Central Europe aesthetics market are Johnson & Johnson Services, Inc (U.S.), GALDERMA LABORATORIES, L.P. (U.S.), Abbvie, Inc (U.S.), Merz Pharmaceuticals, LLC. (U.S.), POLYTECH Health & Aesthetics GmbH (Germany).

Central Europe Aesthetics Market

Market Developments

  • In December 2021, Allergan Aesthetics, a subsidiary of AbbVie, acquired Soliton, Inc., a medical technology company. This strategic acquisition bolstered Allergan Aesthetics' offerings by adding innovative, non-invasive body contouring treatments to its portfolio. These new treatments align with the growing demand for non-surgical aesthetic solutions, further enhancing the company's position in the aesthetics market and expanding its offerings for patients seeking effective and non-invasive ways to address body contouring and appearance enhancement.
  • In 2020, Galderma, a Swiss pharmaceutical company, achieved approval from the U.S. Food and Drug Administration for Restylane Kysse. This dermal filler product is designed for lip augmentation and the correction of upper perioral rhytids, or wrinkles around the upper lips. It is specifically indicated for use in adults aged 21 years and older. This regulatory approval signifies an expanded range of aesthetic solutions for individuals seeking lip enhancement and addressing perioral wrinkles.
  • In 2020, 3D-Lipo Ltd introduced 3D-Powersculpt in the United Kingdom, marking a significant advancement in body shaping and muscle toning technology. This innovative device offers the remarkable benefit of achieving results equivalent to 20,000 crunches or squats with just one treatment. This breakthrough underscores a more efficient and non-invasive approach to enhancing muscle tone and reshaping the body, providing a convenient and appealing solution for individuals seeking improved fitness and aesthetics.
  • In September 2020, Allergan Aesthetics, a division of AbbVie, and Skinbetter Science introduced the DREAM: Driving Racial Equity in Aesthetic Medicine initiative. The Dream Initiative is dedicated to promoting racial and ethnic diversity, inclusivity, respect, and understanding within plastic surgery and dermatology. It aims to drive positive changes and foster a more equitable and inclusive environment in the field of aesthetic medicine, with a focus on embracing diversity and respecting all individuals.

Regional Analysis

Geographically, the countries covered in the Central Europe aesthetics market report are Germany, Russia, Denmark, Poland, Belgium, Ireland, Austria, Switzerland, Netherlands, Czech Republic, Ukraine, Rest of CIS Countries and Rest of Central Europe.

As per Data Bridge Market Research analysis:

Germany is estimated to be the fastest-growing region in the Central Europe aesthetics market in the forecast period 2023-2030

Germany is anticipated to experience the highest growth rate in aesthetics due to the accessibility of non-invasive surgical procedures. The country witnessed a rise in surgical interventions alongside a growing trend of beauty clinics. This combination drives market demand as individuals seek minimally invasive aesthetic treatments and enhancements. Germany's flourishing aesthetics industry reflects the increasing consumer interest in non-surgical cosmetic procedures and overall aesthetics maintenance.

For more detailed information about the Central Europe aesthetics market report, click here – https://www.databridgemarketresearch.com/reports/central-europe-aesthetics-market


Client Testimonials